termId
stringlengths 7
10
| termName
stringlengths 2
104
| treeNumbers
stringlengths 2
608
|
|---|---|---|
D000089042 | Coptis chinensis | ['B01.875.800.575.912.250.836.750.229.500'] |
D000089062 | Biosecurity | ['N04.452.910.150'] |
D000089083 | Body Odor | ['C23.888.104'] |
D000089102 | Infodemic | ['L01.143.443.500'] |
D000089122 | Adolescent Fathers | ['F01.829.263.875.100.500', 'I01.880.853.150.688.210.500', 'M01.620.390.500'] |
D000089142 | Fractional Exhaled Nitric Oxide Testing | ['E01.370.100.500'] |
D000089162 | Genitourinary Agents | ['D27.505.954.493'] |
D000089183 | Axial Spondyloarthritis | ['C05.116.900.853.625.800.744', 'C05.550.069.340', 'C05.550.114.865.800.744'] |
D000089202 | Non-Radiographic Axial Spondyloarthritis | ['C05.116.900.853.625.800.744.250', 'C05.550.069.340.250', 'C05.550.114.865.800.744.250'] |
D000089262 | Senescence-Associated Secretory Phenotype | ['G04.043.445', 'G07.345.124.130.445'] |
D000089282 | Secretome | ['A12.895', 'G03.500.500'] |
D000089322 | Senotherapeutics | ['D27.505.954.803'] |
D000089323 | Geroscience | ['H01.158.595', 'H02.403.355.500'] |
D000089342 | Canonical Correlation Analysis | ['E05.318.740.150.500.250', 'N05.715.360.750.125.500.250', 'N06.850.520.830.150.500.250'] |
D000089382 | Oxygen Saturation | ['G03.707'] |
D000089502 | Antiglaucoma Agents | ['D27.505.954.069'] |
D000089582 | Adjuvants, Vaccine | ['D26.650.064.500', 'D27.505.696.477.067.500', 'D27.720.744.064.500'] |
D000089622 | Doublecortin Domain Proteins | ['D12.776.220.600.450.125'] |
D000089662 | Doublecortin Protein | ['D12.776.220.600.450.125.500', 'D12.776.631.560.113'] |
D000089682 | Cellular Automata | ['E05.599.032', 'L01.224.050.531', 'L01.224.160.187'] |
D000089703 | Fibroblast Growth Factor-23 | ['D12.644.276.624.600'] |
D000089742 | Doublecortin-Like Kinases | ['D08.811.913.696.620.682.700.275', 'D12.776.220.600.450.125.750', 'D12.776.476.563.275'] |
D000089762 | Multidrug Resistance-Associated Protein 2 | ['D12.776.157.530.100.304.750', 'D12.776.157.530.450.074.500.500.500.750', 'D12.776.543.585.100.304.750', 'D12.776.543.585.450.074.500.500.500.750'] |
D000089783 | Defective Interfering Viruses | ['B04.265.135'] |
D000089802 | Chronic Limb-Threatening Ischemia | ['C14.907.137.126.307.500.500', 'C14.907.617.671.500', 'C23.550.291.500.298', 'C23.550.513.178'] |
D000089803 | Myofascial Release Therapy | ['E02.190.599.750.750.750', 'E02.779.867.880.750.750', 'E02.831.535.867.880.750.750'] |
D000089804 | Shelterin Complex | ['A11.284.430.106.279.345.190.160.845.500', 'D05.500.918', 'D12.776.260.735.625', 'D12.776.660.235.700.625', 'D12.776.664.981', 'G05.360.160.845.500'] |
D000089822 | Birth Cohort | ['M01.060.261'] |
D000089823 | Life Course Perspective | ['F02.970.250'] |
D000089842 | Xenotropic and Polytropic Retrovirus Receptor | ['D12.776.543.750.695.977', 'D12.776.543.750.830.925'] |
D000089862 | Haptic Technology | ['J01.293.069.375', 'J01.897.380', 'J01.897.441.500', 'L01.224.160.875.500', 'L01.296.555.500'] |
D000089882 | Antimicrobial Peptides | ['D12.644.066'] |
D000089922 | Haptic Interfaces | ['L01.224.230.260.115.625'] |
D000089942 | Viral Pseudotyping | ['E01.370.225.875.960', 'E05.200.875.960', 'E05.393.880'] |
D000089943 | Sleep Quality | ['F02.830.855.734.500'] |
D000089944 | Core Stability | ['F02.830.816.541.752.500', 'G07.888.750.500.500', 'G11.427.690.500', 'G11.561.790.541.595.500'] |
D000089945 | Salvia hispanica | ['B01.875.800.575.912.250.583.520.922.375'] |
D000089962 | Reynoutria | ['B01.875.800.575.912.250.825.569'] |
D000089963 | Besnoitia | ['B01.043.075.189.250.750.275'] |
D000089964 | Anticoagulant Reversal Agents | ['D27.505.954.502.270.463.046'] |
D000089965 | Erythema Ab Igne | ['C17.800.229.100', 'C23.888.885.328.500', 'C26.200.413'] |
D000089982 | ADP-Ribosylation Factor 6 | ['D08.811.277.040.330.300.400.100.050', 'D12.776.157.325.515.100.550', 'D12.776.476.338.400.100.050'] |
D000089983 | Escitalopram | ['D02.092.831.230', 'D02.626.295', 'D03.633.100.127.203'] |
D000090002 | Stromal Vascular Fraction | ['A11.329.830.500.500', 'A11.872.590.500.500'] |
D000090003 | Blood Flow Restriction Therapy | ['E02.760.169.063.500.387.125', 'E02.779.483.125', 'E02.831.535.483.125'] |
D000090004 | Ambulatory Care Sensitive Conditions | ['C23.550.291.156', 'E05.318.308.980.438.475.183', 'N05.715.360.300.800.438.375.046', 'N06.850.520.308.980.438.475.012'] |
D000090005 | Epidemiological Models | ['E05.599.395.121'] |
D000090006 | Molybdenum Cofactors | ['D08.211.532'] |
D000090007 | CLC-2 Chloride Channels | ['D12.776.157.530.400.175.094', 'D12.776.543.550.450.175.094', 'D12.776.543.585.400.175.094'] |
D000090022 | Chemometrics | ['E05.196.168', 'E05.318.740.244', 'N06.850.505.300'] |
D000090023 | Metallothionein 3 | ['D12.776.556.670.500', 'D12.776.631.540'] |
D000090042 | Sentiment Analysis | ['G17.035.250.750', 'L01.224.050.375.815', 'L01.313.500.750.280.199.750', 'L01.470.625.750'] |
D000090043 | Abdominal Core | ['A01.923.112'] |
D000090044 | Rapid On-site Evaluation | ['N04.590.874.500.750'] |
D000090062 | Kruppel-Like Factor 4 | ['D12.776.260.522.532', 'D12.776.930.375.532'] |
D000090063 | Proto-Oncogene Mas | ['D12.776.543.750.695.047.313', 'D12.776.543.750.750.130.375', 'D12.776.624.664.700.166'] |
D000090082 | Climate Models | ['E05.599.520', 'I01.320.250'] |
D000090103 | Antiviral Restriction Factors | ['D12.776.066'] |
D000090104 | Dacryocystography | ['E01.370.350.240'] |
D000090122 | Livedoid Vasculopathy | ['C14.907.355.830.573', 'C17.800.862.406'] |
D000090123 | Viperin Protein | ['D12.776.066.500'] |
D000090124 | Intestinal Failure | ['C06.405.469.462'] |
D000090142 | European Alpine Region | ['Z01.542.025'] |
D000090143 | Medication Review | ['N04.452.528.467', 'N04.590.659'] |
D000090182 | Cognitive Psychology | ['F04.096.628.017', 'F04.096.628.255.750'] |
D000090203 | Zn-Alpha-2-Glycoprotein | ['D06.472.699.042.875', 'D09.400.430.998', 'D12.644.276.024.875', 'D12.644.548.011.875', 'D12.776.395.985', 'D12.776.467.024.875', 'D23.529.024.875'] |
D000090204 | Mesothelin | ['D09.400.430.890.448.550', 'D12.644.360.410', 'D12.776.395.550.448.550', 'D12.776.476.410', 'D12.776.543.484.500.588', 'D12.776.543.550.418.550', 'D23.050.301.609'] |
D000090205 | DNA Methyltransferase 3A | ['D08.811.913.555.500.350.100.500.750'] |
D000090206 | Gaslighting | ['L01.143.790.750'] |
D000090208 | Gamification | ['I02.487', 'L01.224.900.340'] |
D000090222 | Low-Value Care | ['N03.219.151.725'] |
D000090242 | Computerized Adaptive Testing | ['I02.594.500'] |
D000090243 | Nucleophosmin | ['D12.776.660.694'] |
D000090262 | Hunting | ['I03.400', 'I03.450.642.637'] |
D000090263 | Leucine-Rich Repeat Proteins | ['D12.776.529'] |
D000090264 | UDP-Glucuronosyltransferase 1A9 | ['D08.811.913.400.450.480.750'] |
D000090265 | Klotho Proteins | ['D08.811.277.450.426.500', 'D12.776.543.750.750.400.370.250'] |
D000090266 | Chromobox Protein Homolog 5 | ['D12.776.660.235.300', 'D12.776.664.235.300'] |
D000090267 | Mast Cell Activation Syndrome | ['C20.762.500'] |
D000090282 | Predatory Journals as Topic | ['L01.462.500.682.829.678.500'] |
D000090303 | Focal Facial Dermal Dysplasias | ['C16.131.077.350.568', 'C16.131.831.350.568', 'C16.320.850.250.568', 'C17.800.804.350.568', 'C17.800.827.250.568'] |
D000090322 | Homeobox Protein Nkx-2.2 | ['D12.776.260.400.230', 'D12.776.660.415', 'D12.776.930.321'] |
D000090323 | Mannose Receptor | ['D12.776.503.280.508', 'D12.776.503.311.750', 'D12.776.543.750.002'] |
D000090324 | Tumor Protein, Translationally-Controlled 1 | ['D12.644.360.963', 'D12.776.476.941', 'D12.776.624.720'] |
D000090342 | Plant Cone | ['A18.024.625'] |
D000090362 | Mast Cell Activation Disorders | ['C20.762'] |
D000090382 | Prolonged Grief Disorder | ['F01.470.142.555', 'F03.950.625'] |
D000090402 | Digit Ratios | ['E01.370.600.024.350', 'E05.041.124.473', 'N06.850.505.200.100.550'] |
D000090422 | Dissolved Organic Matter | ['D02.332', 'D20.313'] |
D000090462 | Infodemiology | ['L01.313.750.500'] |
D000090463 | Iron Deficiencies | ['C18.452.565.400'] |
D000090464 | Laboratories, Clinical | ['N02.278.487.205'] |
D000090465 | Light Pollution | ['N06.850.460.505'] |
D000090502 | Phase Variation | ['G05.365.693'] |
D000090522 | Mass Gatherings | ['F01.145.813.542', 'F01.145.875.281.500'] |
D000090542 | Homozygous Familial Hypercholesterolemia | ['C16.320.565.398.481.500', 'C18.452.584.500.500.644.475.500', 'C18.452.584.563.481.500', 'C18.452.648.398.481.500'] |
D000090562 | Luciferins | ['D02.578'] |
D000090602 | Collagen Type I, alpha 1 Chain | ['D05.750.078.280.300.100.500'] |
D000090622 | Mitochondrial Precursor Protein Import Complex Proteins | ['D05.500.469', 'D05.500.890.563', 'D12.776.543.585.475.594', 'D12.776.575.750.594'] |
D000090642 | Anaerobic Ammonia Oxidation | ['G02.111.587.125', 'G02.607.560.125', 'G16.500.768.125'] |